中药促血管生成潜力:机制全面解析
本篇综述检索2003至2024年PubMed、Web of Science和Google Scholar数据库,系统总结中药提取物、传统方剂及关键植物化学物的促血管生成效应与分子机制。结果显示中药主要通过上调VEGF、Notch、MAPK、HIF-1α及PI3K-Akt等通路促进血管内皮细胞存活、增殖与迁移。证据提示中药是促血管生成治疗的有前景候选药物,需进一步研发以充分发挥其治疗价值。
要点
- 中药提取物、方剂及植物化学物具有显著促血管生成效应
- 机制涉及VEGF、Notch、MAPK、HIF-1α及PI3K-Akt等多通路
- 中药促血管生成作用为血管功能不全相关疾病提供潜在治疗选择
核心结论
- 多种中药提取物、方剂和关键植物化学物显示出显著促血管生成效应。
- 中药促血管生成机制具有多面性,主要涉及VEGF、Notch、MAPK、HIF-1α和PI3K-Akt等通路的上调。
- 证据表明中药是促血管生成治疗的有前景候选药物,值得进一步研究开发以充分发挥其治疗价值。
研究设计与样本
- 检索PubMed、Web of Science和Google Scholar数据库,覆盖2003至2024年发表的文献。
- 使用Pro-angiogenic、Angiogenesis、Phytochemicals、Traditional Chinese Medicine等关键词检索相关研究。
- 对检索文献进行评估、总结和综合,以全面概述中药促血管生成效应及其分子机制。
主要发现
- 系统总结了血管生成的关键分子机制,包括VEGF、Notch、血管生成素-Tie、成纤维细胞生长因子、血小板衍生生长因子和HIF通路。
- 中药通过促进细胞存活、增殖和迁移发挥促血管生成效应,主要涉及上调VEGF、Notch信号、MAPK信号、HIF-1α和PI3K-Akt信号通路。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
ETHNOPHARMACOLOGICAL RELEVANCE: Pro-angiogenic therapy aims to stimulate the formation of new blood vessels, thereby enhancing blood flow to tissues and organs. Current strategies, such as growth factors, gene therapy, and cell-based approaches, are widely employed to promote angiogenesis. However, these interventions often suffer from off-target effects and limited efficacy due to the complex regulation of angiogenesis. Chinese herbal medicine (CHM) provides a rich source of therapeutic agents and offers promising alternatives for the treatment of vascular insufficiency-related disorders. AIM OF THE STUDY: This review aims to summarise current research on the pro-angiogenic effects and underlying molecular mechanisms of CHM, including herbal extracts, traditional formulations and key bioactive phytochemicals. METHODS: A comprehensive literature search was conducted using electronic databases, including PubMed, Web of Science, and Google Scholar, covering publications from 2003 to 2024. Keywords including "Pro-angiogenic", "Angiogenesis", "Phytochemicals", "Traditional Chinese Medicine", "Natural compounds", "Phytomedicine", "Plant medicine", "Botanical drugs" and "Chinese herbal medicine" were used to retrieve relevant studies. The retrieved articles were then assessed, summarised and synthesized to provide a comprehensive overview of the pro-angiogenic effects of CHMs and the molecular mechanisms underpinning these effects. RESULTS: We systematically summarised the key molecular mechanisms involved in angiogenesis, including the vascular endothelial growth factor (VEGF), notch signalling, angiopoietin-tie, fibroblast growth factor, platelet-derived growth factor and hypoxia-inducible factor (HIF) pathways. Mechanistically, CHMs exert pro-angiogenic effects through promoting cell survival, proliferation, and migration, primarily through the upregulation of VEGF, Notch signalling, MAPK signalling, HIF-1α, and PI3K- Protein Kinase B (Akt) signalling pathways. CONCLUSION: Multiple Chinese herbal extracts, formulations and key phytochemicals demonstrate significant pro-angiogenic effects. The mechanisms of these effects are multifaceted. The evidence highlights the potential of CHMs as promising candidates for pro-angiogenic therapy, warranting the need for further research and development to fully harness their therapeutic value.
引用
- Munir MM, Zhou X, Chang D, et al. Exploring the pro-angiogenic potential of Chinese herbal medicines: a comprehensive insight into mechanisms. J Ethnopharmacol. 2025. PMID: 40513922. doi:10.1016/j.jep.2025.120132
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。